Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020, 164(4):417-424 | DOI: 10.5507/bp.2019.055

Effects of dexmedetomidine versus remifentanil on mothers and neonates during cesarean section under general anesthesia

Zhiqiang Yua,b, Peijun Zhangb, Haiyun Wanga, Li Zhangb, Wei Weib, Wenqian Fangb, Xingbo Muc
a Department of Anesthesiology, The Third Central Clinical College of Tianjin Medical University, Tianjin Third Central Hospital, Nankai University Affinity the Third Central Hospital, Tianjin Institute of Hepatobiliary Disease, Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin 300170, China
b Department of Anesthesiology, Central Hospital of gynecology and obstetrics, Tianjin 300100, China
c Neonatal Department,Tianjin Central Hospital of gynecology and obstetrics, Tianjin 300100, China

Background and Aims: Dexmedetomidine and remifentanil use in obstetric general anesthesia is controversial. This study aimed to compare the effects of remifentanil and dexmedetomidine on mothers and neonates during cesarean section under general anesthesia.

Methods: A total of 120 patients scheduled for elective cesarean section under general anesthesia were randomly allocated to dexmedetomidine (D), remifentanil (R), and control (C) groups. Anesthesia was induced with propofol and muscle relaxants in all groups. Anesthesia in groups D and R was induced with dexmedetomidine (induction, 0.5 µg/kg; maintenance, 0.5 µg/kg.h) and remifentanil (induction, 0.5 µg/kg; maintenance, 2 µg/kg.h), respectively, until birth. Group C received equivalent volumes of normal saline. Mean arterial blood pressure (MAP), heart rate (HR), plasma catecholamine, visual analog pain score (VAS), and total tramadol consumption at 1, 2, and 3 hours after extubation were recorded. Neonatal effects were assessed by Apgar scores and umbilical blood gas analysis.

Results: Post induction, MAP was significantly higher in group D compared to groups C and R, and significantly lower in group R than in group C. At intubation/skin incision and delivery, MAP, HR, and plasma epinephrine and norepinephrine concentrations were significantly lower in groups D and R than in group C. Compared to group R, MAP was significantly higher, and HR, plasma epinephrine, and norepinephrine concentrations were significantly lower in group D. Compared with groups C and D, the percentage of neonates with Apgar score < 7 was higher in group R at 1 min after delivery. Compared with groups C and R, the VAS was significantly lower in group D at 1 and 2 h postoperatively. Total tramadol consumption was significantly lower in group D at 3 hours postoperatively.

Conclusion: During general anesthesia for cesarean section, remifentanil demonstrated better control of hemodynamic stability, while dexmedetomidine demonstrated better neonatal Apgar scores, postoperative analgesia, and decreased catecholamine release. Trial Registration: Chinese Clinical Trial Register (ChiCTR) - ChiCTR1800017125

Keywords: general anesthesia, cesarean section, remifentanil, dexmedetomidine

Received: August 21, 2019; Revised: October 3, 2019; Accepted: November 4, 2019; Prepublished online: November 19, 2019; Published: December 15, 2020  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Yu, Z., Zhang, P., Wang, H., Zhang, L., Wei, W., Fang, W., & Mu, X. (2020). Effects of dexmedetomidine versus remifentanil on mothers and neonates during cesarean section under general anesthesia. Biomedical papers164(4), 417-424. doi: 10.5507/bp.2019.055
Download citation

Supplementary files

Download fileBiomed164-4-417-424-sup.pdf

File size: 105.86 kB

References

  1. Gin T,O'Meara ME, Kan AF,Leung RK, Tan P, Yau G. Plasma catecholamines and neonatal condition after induction of anaesthesia with propofol or thiopentone at caesarean section. Br J Anaesth 1993;70:311-6. Go to original source... Go to PubMed...
  2. Sulaiman S, Karthekeyan RB, Vakamudi M, Sundar AS, Ravullapalli H, Gandham R. The effects of dexmedetomidine on attenuation of stress response to endotracheal intubation in patients undergoing elective off-pump coronary artery bypass grafting. Ann Card Anaesth 2012;15:39-43. Go to original source... Go to PubMed...
  3. Kunisawa T, Ueno M, Kurosawa A, Nagashima M, Hayashi D, Sasakawa T, Suzuki A, Takahata O, Iwasaki H. Dexmedetomidine can stabilize hemodynamics and spare anesthetics before cardiopulmonary bypass. J Anesth 2011;25:818-22. Go to original source... Go to PubMed...
  4. Winterhalter M, Brandl K, Rahe-Meyer N, Osthaus A, Hecker H, Hagl C, Adams H A, Piepenbrock S. Endocrine stress response and inflammatory activation during CABG surgery. A randomized trial comparing remifentanil infusion to intermittent fentanyl. Eur J Anaesthesiol 2008;25:326-35. Go to original source... Go to PubMed...
  5. Heesen M, Klöhr S, Hofmann T, Rossaint R, Devroe S, Straube S, Van de Velde M. Maternal and foetal effects of remifentanil for general anaesthesia in parturients undergoing caesarean section: a systematic review and meta-analysis. Acta Anaesthesiol Scand 2013 57:1-8. Go to original source... Go to PubMed...
  6. Kart K, Hanci A. Effects of remifentanil and dexmedetomidine on the mother's awareness and neonatal Apgar scores in caesarean section under general anaesthesia. J Int Med Res 2018;46(5):1846-54. Go to original source... Go to PubMed...
  7. Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine. Clin Pharmacokinet 2017;56:893-913. Go to original source... Go to PubMed...
  8. Yoo KY, Jeong CW, Park BY, Kim SJ, Jeong ST, Shin MH, Lee J. Effects of remifentanil on cardiovascular and bispectral index responses to endotracheal intubation in severe pre-eclamptic patients undergoing Caesarean delivery under general anaesthesia. Br J Anaesth 2009;102(6):812-19. Go to original source... Go to PubMed...
  9. Park BY, Jeong CW, Jang EA, Kim SJ, Jeong ST, Shin MH, Lee J, Yoo KY. Dose-related attenuation of cardiovascular responses to tracheal intubation by intravenous remifentanil bolus in severe pre-eclamptic patients undergoing Caesarean delivery. Br J Anaesth 2011;106(1):82-7. Go to original source... Go to PubMed...
  10. White LD, Hodsdon A, An GH, Thang C, Melhuish TM, Vlok R. Induction opioids for caesarean section under general anaesthesia: a systematic review and meta-analysis of randomised controlled trials. Int J Obstet Anesth 2019;40:4-13. doi: 10.1016/j.ijoa.2019.04.007 Go to original source... Go to PubMed...
  11. Draisci G, Valente A, Suppa E, Frassanito L, Pinto R, Meo F, De Sole P, Bossù E, Zanfini BA. Remifentanil for cesarean section under general anesthesia: effects on maternal stress hormone secretion and neonatal well-being: a randomized trial. Int J Obstet Anesth 2008;17:130-6. Go to original source... Go to PubMed...
  12. Singh S, Singh A. Dexmedetomidine induced catecholamine suppression in pheochromocytoma. J Nat Sci Biol Med 2014;5:182. Go to original source... Go to PubMed...
  13. Moura E, Afonso J, Hein L, Vieira-Coelho MA. Alpha2-adrenoceptor subtypes involved in the regulation of catecholamine release from the adrenal medulla of mice. Br J Pharmacol 2006;149:1049. Go to original source... Go to PubMed...
  14. Ngan Kee WD1, Khaw KS, Ma KC, Wong AS, Lee BB, Ng FF. Maternal and neonatal effects of remifentanil at induction of general anesthesia for cesarean delivery: a randomized, double- blind, controlled trial. Anesthesiology 2006;104:14-20. Go to PubMed...
  15. Yoo KY, Kang DH, Jeong H, Jeong CW, Choi YY, Lee J. A dose-response study of remifentanil for attenuation of the hypertensive response to laryngoscopy and tracheal intubation in severely preeclamptic women undergoing caesarean delivery under general anaesthesia. Int J Obstet Anesth 2013;22:10-18. Go to original source... Go to PubMed...
  16. Eskandr AM, Metwally AA, Ahmed AA, Elfeky EM, Eldesoky IM, Obada MA, Abd-Elmegid OA. Dexmedetomidine as a part of general anaesthesia for caesarean delivery in patients with pre-eclampsia. Eur J Anaesthesiol 2018;35(5):1-7. Go to original source... Go to PubMed...
  17. Welzing L, Ebenfeld S, Dlugay V, Wiesen MH, Roth B, Mueller C. Remifentanil degradation in umbilical cord blood of preterm infants. Anesthesiology 2011;114:570-7. Go to original source... Go to PubMed...
  18. Ngan Kee WD, Khaw KS, Ma KC, Wong AS, Lee BB, Ng FF. Maternal and neonatal effects of remifentanil at induction of general anesthesia for cesarean delivery: a randomized, doubleblind, controlled trial. Anesthesiology 2006;104:14-20. Go to original source... Go to PubMed...
  19. Booth CM, Buckley H, Wheatly S, Maguire S. Attenuation of the hypertensive response to tracheal intubation in patients with severe preeclampsia: a UK postal survey. Int J Obstet Anesth 2011;20:102-3. Go to original source... Go to PubMed...
  20. Yu M, Han C, Jiang X, Wu X, Yu L, Ding Z. Effect and placental transfer of dexmedetomidine during caesarean section under general anaesthesia. Basic Clin Pharmacol Toxicol 2015;117:204-8. Go to original source... Go to PubMed...
  21. Shen MK, Wu ZF, Zhu AB, He LL, Shen XF, Yang JJ, Feng SW. Remifentanil forlabour analgesia: a doubleblinded, randomized controlled trial of maternal and neonatal effects of patient-controlled analgesia versus continuous infusion. Anaesthesia 2013;68:236-44. Go to original source... Go to PubMed...
  22. Abu-Halaweh SA, Al Oweidi AK, Abu-Malooh H, Zabalawi M, Alkazaleh F, Abu-Ali H, Ramsay MA. Intravenous dexmedetomidine infusion for labour analgesia in patient with preeclampsia. Eur J Anaesthesiol 2009;26:86-7. Go to original source... Go to PubMed...
  23. Min Yu, Chuanbao Han, Xiuhong Jiang, Xia Wu, Li Yu , Zhengnian Ding. Effect and placental transfer of dexmedetomidine during caesarean section under general anaesthesia. Basic Clin Pharmacol Toxicol 2015;117:204-8. Go to original source... Go to PubMed...
  24. Yoo H, Iirola T, Vilo S, Manner T, Aantaa R, Lahtinen M, Scheinin M, Olkkola KT, Jusko WJ. Mechanism-based population pharmacokinetic and pharmacodynamic modeling of intravenous and intranasal dexmedetomidine in healthy subjects. Eur J Clin Pharmacol 2015;71:1197-207. Go to original source... Go to PubMed...
  25. Lee S, Kim BH, Lim K, Stalker D, Wisemandle W, Shin SG, Jang IJ, Yu KS.Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects. J Clin Pharm Ther 2012;37:698-703. Go to original source... Go to PubMed...
  26. Iirola T, Aantaa R, Laitio R, Kentala E, Lahtinen M, Wighton A, Garratt C, Ahtola-Sätilä T, Olkkola KT. Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients. Crit Care 2011;15:R257. Go to original source... Go to PubMed...
  27. Zhang T, Deng Y, He P, He Z, Wang X. Effects of mild hypoalbuminemia on the pharmacokinetics and pharmacodynamics of dexmedetomidine in patients after major abdominal or thoracic surgery. J Clin Anesth 2015;27:632-7. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.